|Last Price||Today's Change||52-Week Range||Trading Volume|
|62.07||-0.02 (-0.03%)||46.30 - 64.44||3.7 million (Below Avg)|
Market data as of 4:04PM 01/23/15. Quotes are delayed by at least 15 min.
Seattle Genetics and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate Combination of Adcetris® (Brentuximab Vedotin) and Opdivo® (Nivolumab) in Hematologic Malignancies
01/12/2015 8:00 AM ET